Both Interleukin-3 and Interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood

Stem Cells and Development

Volumn 19, Issue 3, 2010, Pages 413-421

  Bordeaux Rego, Pedro ^a   Luzo, Angela ^a   Costa, Fernando Ferreira ^a   Olalla Saad, Sara Teresinha ^a   Crosara Alberto, Daniella Pereira ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STEM CELL FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL EXPANSION;

EID: 77949619008     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0098     Document Type: Article

References (50)

1. Miraglia S, W Godfrey, AH Yin, K Atkins, R Warnke, JT Holden, RA Bray, EK Waller and DW Buck. (1997). A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90:5013-5021.
2. Yin AH, S Miraglia, ED Zanjani, G Almeida-Porada, M Ogawa, AG Leary, J Olweus, J Kearney and DW Buck. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.
3. Wynter EA, D Buck, C Hart, R Heywood, LH Coutinho, A Clayton, JA Rafferty, D Burt, G Guenechea, JA Bueren, D Gagen, LJ Fairbairn, BI Lord and G Testa. (1998). CD34 AC133 cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16:387-396.
4. Corbeil D, K Roper, A Hellwig, M Tavian, S Miraglia, SM Watt, PJ Simmons, B Peault, DW Buck and WB Huttner. (2000). The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275:5512-5520.
5. Padovan CS, K Jahn, T Birnbaum, P Reich, P Sostak, M Strupp and A Straube. (2003). Expression of neuronal markers in differentiated marrow stromal cells and CD133 stem-like cells. Cell Transpl 12:839-848.
6. Gehling UM, S Ergun, U Schumacher, C Wagener, K Pantel, M Otte, G Schuch, P Schafhausen, T Mende, N Kilic, K Kluge, B Schafer, DK Hossfeld and W Fiedler. (2000). In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95:3106-3112.
7. Quirici N, D Soligo, L Caneva, F Servida, P Bossolasco and GL Deliliers. (2001). Differentiation and expansion of endothelial cells from human bone marrow CD133 cells. Br J Haematol 115:186-194.
8. Torrente Y, M Belicchi, M Sampaolesi, F Pisati, M Meregalli, G D'Antona, R Tonlorenzi, L Porretti, M Gavina, K Mamchaoui, MA Pellegrino, D Furling, V Mouly, GS Butler-Browne, R Bottinelli, G Cossu and N Bresolin. (2004). Human circulating AC133 stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114:182-195.
9. Ueda T, K Tsuji, H Yoshino, Y Ebihara, H Yagasaki, H Hisakawa, T Mitsui, A Manabe, R Tanaka, K Kobayashi, M Ito, K Yasukawa and T Nakahata. (2000). Expansion of human NOD/SCIDrepopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 105:1013-1021.
10. Gammaitoni L, KC Weisel, M Gunetti, KD Wu, S Bruno, S Pinelli, A Bonati, M Aglietta, MA Moore and W Piacibello. (2004). Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood 103:4440-4448.
11. Summers YJ, CM Heyworth, EA de-Wynter, CA Hart, J Chang and NG Testa. (2004). AC133 G0 cells from cord blood show a high incidence of longterm culture-initiating cells and a capacity for more than 100 million-fold amplifi cation of colonyforming cells in vitro. Stem Cells 22:704-715.
12. Piacibello W, L Gammaitoni, S Bruno, M Gunetti, F Fagioli, G Cavalloni and M Aglietta. (2000). Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. J Hematother Stem Cell Res 9:945-956.
13. Bruno S, L Gammaitoni, M Gunetti, F Sanavio, F Fagioli, M Aglietta and W Piacibello. (2001). Different growth factor requirements for the ex vivo amplifi cation of transplantable human cord blood cells in a NOD/SCID mouse model. J Biol Regul Homeost Agents 15:38-48
14. Encabo A, E Mateu, F Carbonell-Uberos and MD Minana. (2003). IL-6 precludes the differentiation induced by IL-3 on expansion of CD34 cells from cord blood. Haematologica 88:388-395.
15. Nikolova T, M Wu, K Brumbarov, R Alt, H Opitz, KR Boheler, M Cross and AM Wobus. (2007). WNT-conditioned media differentially affect the proliferation and differentiation of cord bloodderived CD133 cells in vitro. Differentiation 75:100-111.
16. Kucia M, M Halasa, M Wysoczynski, M Baskiewicz-Masiuk, S Moldenhawer, E Zuba-Surma, R Czajka, W Wojakowski, B Machalinski and MZ Ratajczak. (2007). Morphological and molecular characterization of novel population of CXCR4 SSEA-4 Oct-4 very small embryonic like cells purified from human cord blood: preliminary report. Leukemia 21:297-303.
17. Zhao Y, H Wang and T Mazzone. (2006). Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312:2454-2464.
18. Baal N, K Reisinger, H Jahr, RM Bohle, O Liang, K Munstedt, CV Rao, KT Preissner and MT Zygmunt. (2004). Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb Haemost 924:767-775.
19. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(delta delta C(T)). Methods 25:402-408.
20. Dahl C, HJ Hoffmann H Saito and PO Schiotz. (2004). Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy 59(10):1087-1096.
21. Reyes M, T Lund, T Lenvik, D Aguiar, L Koodie and CM Verfaillie. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625.
22. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
23. D'Ippolito G, S Diabira, GA Howard, P Menei, BA Roos and PC Schiller. (2004). Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981.
24. Go MJ, C Takenaka and H Ohgushi. (2008). Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp Cell Res 10:1147-1154.
25. Williams DE, P De Vries, AE Namen, MB Widmer and SD Lyman. (1992). The steel factor. Dev Biol 151:368-376.
26. Rosnet O, C Schiff, MJ Pebusque, S Marchetto, C Tonnelle, Y Toiron, F Birg, D Birnbaum and O Rosnet. (1993). Human FLT3/ FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82:1110-1119.
27. Matthews W, CT Jordan, GW Wiegand, D Pardoll and IR Lemischka. (1991). A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143-1152.
28. Small D, M Levenstein, E Kim, C Carow, S Amin, P Rockwell, L Witte, C Burrow, MZ Ratajczak and AM Gewirtz. (1994). STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34 human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459-463.
29. Osawa M, K Nakamura, N Nishi, N Takahasi, Y Tokuomoto, H Inoue and H Nakauchi. (1996). In vivo self-renewal of c-Kit Sca-1 Lin(low) hemopoietic stem cells. J Immunol 156:3207-3214.
30. Young JC, E Bruno, KM Luens, S Wu, M Backer and LJ Murray. (1996). Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34 progenitor cells from single CD34Thy-1Lin- primitive progenitor cells. Blood 88:1619-1631.
31. Kobayashi M, JH Laver, T Kato, H Miyazaki and M Ogawa. (1996). Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429-436.
32. Yoshida M, K Tsuji, Y Ebihara, K Muraoka, R Tanaka, H Miyazaki and T Nakahata. (1997). Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serum-free culture. Br J Haematol 98:254-264.
33. Satoh T, Y Uehara and Y Kaziro. (1992). Inhibition of interleukin 3 and granulocyte-macrophage colony-stimulating factor stimulated increase of active ras.GTP by herbimycin A, a specific inhibitor of tyrosine kinases. J Biol Chem 267:2537-2541.
34. Vojtek AB, SM Hollenberg and JA Cooper. (1993). Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205-214.
35. Silvennoinen O, BA Witthuhn, FW Quelle, JL Cleveland, T Yi and JN Ihle. (1993). Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429-8433.
36. Ihle JN, BA Witthuhn, FW Quelle, K Yamamoto, WE Thierfelder, B Kreider and O Silvennoinen. (1994). Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222-227.
37. Yanai T, K Sugimoto, E Takashita, Y Aihara, Y Tsurumaki, T Tsuji and KJ Mori. (1995). Separate control of the survival, the self-renewal and the differentiation of hemopoietic stem cells. Cell Struct Funct 20:117-124.
38. Kaneko K and K Ikebuchi. (1995). The self-renewal process of murine hematopoietic stem cells supported by interleukin-3 and the synergistic factors and the probability of its occurrence. Nippon Ika Daigaku Zasshi 62:41-49.
39. Bonati A, P Lunghi, L Gammaitoni, S Pinelli, E Ridolo and PP Dall'Aglio (2002). MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors. Hematol J 3:105-113.
40. Fargeas CA, AV Fonseca, WB Huttner and D Corbeil. (2006). Prominin-1 (CD133): from progenitor cells to human diseases. Future Lipidol 1:213-225.
41. Beckmann J, S Scheitza, P Wernet, JC Fischer and B Giebel. (2007). Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: Identification of asymmetrically segregating proteins. Blood 109:5494-5501.
42. Rose-John S, J Scheller, G Elson and SA Jones. (2006). Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80(2):227-236.
43. Kristensen DM, M Kalisz and JH Nielsen. (2005). Cytokine signalling in embryonic stem cells. APMIS 113(11-12):756-772.
44. Campard D, M Vasse, S Rose-John, F Poyer, M Lamacz and JP Vannier. (2006). Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133 cells. Stem Cells 24(5):1302-1314.
45. Suzuki T, Y Yokoyama, K Kumano, M Takanashi, S Kozuma, T Takato, T Nakahata, M Nishikawa, S Sakano, M Kurokawa, S Ogawa and S Chiba. (2006). Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells 24:2456-2465.
46. Grskovic B, K Ruzicka, A Karimi, D Qujeq and MM Muller. (2004). Cell cycle analysis of the CD133 and CD133- cells isolated from umbilical cord blood. Clin Chim Acta 343:173-178.
47. Boxal SA, GP Cook, D Pearce, D Bonnet, YM El-Sherbiny, MP Blundell, SJ Howe, JP Leek, AF Markham and EA De-Wynter. (2009). Haematopoietic repopulating activity in human cord blood CD133 quiescent cells. Bone Marrow Transplant 43:627-635.
48. Mitsui K, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K Takahashi, M Maruyama, M Maeda and S Yamanaka. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 30:631-642.
49. Chambers I, D Colby, M Robertson, J Nichols, S Lee, S Tweedie and A Smith. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655.
50. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JP Zucker, MG Guenther, RM Kumar, HL Murray, RG Jenner, DK Gifford, DA Melton, R Jaenisch and RA Young. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:828-830.